EUSA Pharma Ltd - logo

EUSA Pharma Ltd - Company & Market Research Reports

Founded in 2006, EUSA Pharma is a specialty pharmaceutical company that focuses on oncology and oncology supportive care, as well as pain control and critical care products. The company’s products include Caphosol for the treatment of oral mucositis; ProstaScint for imaging the extent and spread of prostate cancer; Quadramet for the treatment of pain in patients and a variety of others. The company is based in Langhorne, Pennsylvania. EUSA Pharma operates as a subsidiary of Essex Bidco Ltd.


Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations - Product Thumbnail Image

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • Report
  • 63 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics - Product Thumbnail Image

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

  • Report
  • 143 Pages
From
Neuroblastoma - Market Insights, Epidemiology and Market Forecast-2027 - Product Thumbnail Image

Neuroblastoma - Market Insights, Epidemiology and Market Forecast-2027

  • Drug Pipelines
  • 128 Pages
From
The Development of Therapeutic Monoclonal Antibody Products - Product Thumbnail Image

The Development of Therapeutic Monoclonal Antibody Products

  • Report
Monoclonal Antibody Based Products - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibody Based Products - Global Strategic Business Report

  • Report
  • 527 Pages
From
The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide - Product Thumbnail Image

The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide

  • Report
  • 235 Pages
From
The ROI of Orphan Drugs-- Ensuring optimal returns (2017) - Product Thumbnail Image

The ROI of Orphan Drugs-- Ensuring optimal returns (2017)

  • Report
From
OpportunityAnalyzer: Huntington's Disease - Opportunity Analysis and Forecast to 2024 - Product Thumbnail Image

OpportunityAnalyzer: Huntington's Disease - Opportunity Analysis and Forecast to 2024

  • Drug Pipelines
  • 250 Pages
From
Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

  • Report
  • 1810 Pages
From
Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

  • Report
  • 897 Pages
From
EUSA Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

EUSA Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 73 Pages
From
EUSA Pharma, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

EUSA Pharma, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 13 Results (Page 1 of 1)
Loading Indicator
adroll